Wikiō NADH 2Na (606-68-8)
ʻO Beta-Nicotinamide adenine dinucleotide disodium salt (NADH 2Na) Mea Kūpili
Product Name | ʻO Beta-Nicotinamide adenine dinucleotide disodium paʻakai (NADH 2Na) |
Hawaiian Name | NADH (disodium paʻakai); Disodium nicotinamide adenine dinucleotide; eta-d-ribofuranosyl-3-pyridinecarboxamide, disodiumsalt; beta-NADH Disodium Salt; Nicotinamide adenine dinucleotide, hōʻemi; |
Kāleka CAS | 606-68-8 |
InChIKey | QRGNQKGQENGQSE-WUEGHLCSSA-L |
SMILE | C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O.[Na+].[Na+] |
Ka Lā Molecular | C21H27N7Na2O14P2 |
Molecular Weight | 709.4 |
Monoisotopic Mass | 709.088661 g / mole |
Point Hoʻolālā | 140-142 ℃ |
kala like 'ole | Melemele |
Shoʻoweliweli temp | 2-8 ℃ |
Palekana | H2O: 50 mg / mL, maopopo i kahi akaka, ʻālani |
noi | Kauka; mea momona a me nā meaʻai e pono ai; |
He aha ia ʻo Beta-Nicotinamide adenine dinucleotide disodium salt (NADH 2Na)?
ʻO NADH kahi ʻano o ka nicotinamide adenine dinucleotide (NAD) enzyme, kahi ʻano coenzyme ʻeleu o kahi hui a me ka huaʻai B3. ʻO NADH (b-Nicotinamide adenine dinucleotide) Disodium paʻakai, hoʻemi ʻia, ʻike ʻia ʻo Nicotinamide adenine dinucleotide, kahi coenzyme i nā hopena redox. ʻO kāna mau hana ma ke ʻano he mea hāʻawi electron regenerating i nā kaʻina catabolic e like me glycolysis, β-oxidation a me ka pōʻai acid citric (pōʻaiapuni Krebs, pōʻaiapuna TCA). Ke komo pū nei ka paʻakai NADH disodium i nā hanana hōʻailona pūnana, no ka laʻana ma ke ʻano he substrate no ka poly (ADP-ribose) polymerases (PARPs) i ka wā o ka DNA hōʻino pane. E like me ka paʻakai disodium o NADH, hoʻohana ʻia ia i ka papaʻai a me nā mea hoʻopili pono i ka mālama ʻana i ka maʻi o Parkinson, ka maʻi luhi mau loa, ka maʻi ʻo Alzheimer a me nā maʻi puʻuwai.
Loaʻa iā Beta-Nicotinamide adenine dinucleotide disodium salt (NADH 2Na)
Ma ke ʻano he coenzyme o nā oxidoreductases, hana nui ka paʻakai NADH disodium i ka hana ikehu o ke kino.
- NADH disodium paʻakai hiki ke alakaʻi i ka maikaʻi o ka noʻonoʻo, ka makaʻala, ka noʻonoʻo, a me ka hoʻomanaʻo. Hiki ke hoʻonui i ka noʻonoʻo noʻonoʻo a hoʻonui paha i ke ʻano. Hiki ke hoʻonui i nā pae ikehu i ke kino a hoʻomaikaʻi i ka metabolism, ka mana o ka lolo a me ka hoʻomanawanui.
- Kōkua i ka poʻe me ke kaumaha o ka maʻi, ke koko kiʻekiʻe a i ʻole ke kiʻekiʻe o ka cholesterol;
- Hoʻonui i ka hana haʻuki;
- Ke hoʻopanee i ke kaʻina hana ʻelemakule a mālama i ka pono o nā hunaola nerve e kākoʻo i ka ʻōnaehana ʻōiwi;
- Hiki ke mālama i ka maʻi o Parkinson, hoʻomaikaʻi i ka hana o nā neurotransmitters i ka lolo o nā mea maʻi me ka maʻi ʻo Parkinson, hoʻemi i ke kīnā ʻole o ke kino a me nā pono lāʻau.
- Hoʻohālikelike i ka maʻi luhi mau loa (CFS), ka maʻi o Alzheimer a me ka maʻi maʻi maʻi;
- Palekana i nā hopena ʻino o kahi lāʻau lāʻau AIDS i kapa ʻia zidovudine (AZT);
- Kūʻē i nā hopena o ka waiʻona ma ke akepaʻa;
- Luhi i ka huakaʻi
ʻO Beta-Nicotinamide adenine dinucleotide disodium paʻakai (NADH 2Na) nā hopena ʻaoʻao:
I kēia manawa, ʻike maluhia ka paʻakai ʻo NADH disodium no ka hapanui o ka poʻe inā hoʻohana kūpono kūpono a me ka manawa pōkole, a hiki i 12 mau pule. ʻAʻole ʻike ka hapa nui o kēlā me kēia hopena i ka wā e lawe ai i ka nui i ʻōlelo ʻia i kēlā me kēia lā, ʻo ia ʻo 10 mg.
Eia nō naʻe, ʻaʻole lawa nā datas e pili ana i ka hoʻohana ʻana o ka paʻakai disodium o NADH i ka wā hapai a me ka hānai holoholona. No laila, pono lākou e noho ma ka ʻaoʻao palekana a pale i ka hoʻohana ʻana.
Reference:
- Birkmayer JG, Vrecko C, Volc D, Birkmayer W. Nicotinamide adenine dinucleotide (NADH) - kahi ala lapaʻau hou i ka maʻi o Parkinson. Hoʻohālikelike o ka noi waha a me ka makua. Acta Neurol Scand Suppl 1993; 146: 32-5.
- Budavari S, hoʻoponopono. Ka Papa Kuhikuhi Merck. 12th ed. Whitehouse Station, NJ: Merck & Co., Inc., 1996.
- Bushehri N, Jarrell ST, Lieberman S, et al. Ua hōʻemi ʻia ʻo Oral ka B-nicotinamide adenine dinucleotide (NADH) i ke kahe o ke koko, lipid peroxidation, a me ka ʻaoʻao lipid ma nā kiʻī hypertensive (SHR). Geriatr Neprol Urol 1998; 8: 95-100.
- Bushehri N, Jarrell ST, Lieberman S, et al. Ua hōʻemi ʻia ʻo Oral ka B-nicotinamide adenine dinucleotide (NADH) i ke kahe o ke koko, lipid peroxidation, a me ka ʻaoʻao lipid ma nā kiʻī hypertensive (SHR). Geriatr Neprol Urol 1998; 8: 95-100.
- Castro-Marrero J, Cordero MD, Segundo MJ, et al. Hoʻonui anei ka waha i kahi coenzyme Q10 a me ka hoʻohui NADH i ka momona a me nā hiʻohiʻona biochemical ma ke akeʻeha o ka maʻi momona? Antioxid Redox Signal 2015; 22 (8): 679-85.
- ʻO Dizdar N, Kagedal B, Lindvall B. Hoʻomaʻamaʻa ʻana i ka maʻi o Parkinson me NADH. ʻO Acta Neurol Scand 1994; 90: 345-7.